An interventional study of hypertonic saline and isotonic saline in Pain, Acute, sponsored by Aalborg University. Recruiting at 1 site in Denmark. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-02.
Sponsored by Aalborg University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Acute Pain with a site in Denmark — 3 open to participants now, 4 under way, none of them phase 3. Acute Pain · Denmark.
Among the 19 studies in Acute Pain with a site in Denmark, this one is the 10th largest by planned enrollment of the 15 interventional ones that give a count, is one of 4 that started in 2022, is one of 7 with no phase, and was the 9th registered.
1,077 studies on the registry are indexed under Acute Pain; 168 are open to participants now.
Browse Acute Pain studies →3 of the 19 studies in Acute Pain with a site in Denmark are open now. Recruiting first, the newest first:
Odense University Hospital · Sites in Denmark
Ages 18+
Kristian Kjær Petersen · Sites in Denmark
Ages 18–45 · Healthy volunteers
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 103 Acute Pain studies recruiting now, 40 (39%) set no upper age limit and 50 (49%) stop at 75 or younger; 21 take children under 18; 24 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 4 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 44 is below the median of 86 across 905 interventional studies indexed under Acute Pain.
Median enrollment 50 across the 15 interventional studies, 144 across the 4 observational. Of the 15 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 19 have an industry lead sponsor. The 10 most frequent:
Aalborg University is the lead sponsor of 183 studies on the registry; 32 are open to participants now.
Aalborg University has 4 studies filed under Acute Pain — fewer than ten, so there is no comparison to draw.
2 of the studies in Acute Pain with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06678217Copenhagen University Hospital, HvidovreDetection of Electrodermal Activity in Pain 1 | 2026-12-01 |
| NCT07930897Odense University HospitalPost-Discharge Pain Management Following Fractures in Adults in the Emergency Department: The POST-PAIN Study | 2027-03-22 |
Add all 2 to your calendar (.ics) → With an account.
Among the 19 studies in Acute Pain with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Pain is a complex, multidimensional, and subjective experience; and although, investigators use a single word "pain", to describe our perception, multiple mechanisms contribute to the generation and maintenance of pain. To help diagnosing and improving pain management, there is a need for developing tools. These tools may include measurements of substances, or biomarkers, in the blood; e.g. small molecules called microRNA and proteins. In these experiments, the investigators would like to investigate how the psychological response to stress and pain alters the impulses in the brain and the content of microRNA and proteins in the blood. The future aim is to identify patients in high risk of developing and maintaining chronic pain and to be able to treat chronic pain efficiently.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: hypertonic saline
Drug: isotonic saline
The site of injections will be determined by palpation of the contracted First Dorsal Interosseus (FDI) muscle. The skin will be cleaned with alcohol before injection. A bolus injection of hypertonic saline (7% NaCl) will be administered to the FDI muscle using a 1 mL syringe with a disposable needle (27G), and 30 the volume of the bolus will be 0.2 mL .
The site of injections will be determined by palpation of the contracted First Dorsal Interosseus (FDI) muscle. The skin will be cleaned with alcohol before injection. A bolus injection of 0.2 mL isotonic saline (9 mg/mL) will be administered to the FDI muscle as control.
Oscillations of the main electroencephalogram (EEG) frequency
Electroencephalographic (EEG) recording will be performed placing a 64-electrodes cap over the scalp according to the 10-20 international system. Oscillations of the main EEG frequency bands (delta, alpha, beta, gamma) from the frontal and parietal lobes will be detected and correlated to the individual pain rate as well as the dimensions of the psychological questionnaires.
Time frame: 10 minutes of recording before isotonic/hypertonic injection
Oscillations of the main electroencephalogram (EEG) frequency
Electroencephalographic (EEG) recording will be performed placing a 64-electrodes cap over the scalp according to the 10-20 international system. Oscillations of the main EEG frequency bands (delta, alpha, beta, gamma) from the frontal and parietal lobes will be detected and correlated to the individual pain rate as well as the dimensions of the psychological questionnaires.
Time frame: 10 minutes of recording after isotonic/hypertonic injection
Perturbation of the electroencephalogram (EEG) rhythms
Electroencephalographic (EEG) recording will be performed placing a 64-electrodes cap over the scalp according to the 10-20 international system. Perturbation of the above-mentioned EEG rhythms will be measured in response to the hypertonic/isotonic saline injection and compared to a resting state baseline recording.
Time frame: 10 minutes of recording before isotonic/hypertonic injection
Perturbation of the electroencephalogram (EEG) rhythms
Electroencephalographic (EEG) recording will be performed placing a 64-electrodes cap over the scalp according to the 10-20 international system. Perturbation of the above-mentioned EEG rhythms will be measured in response to the hypertonic/isotonic saline injection and compared to a resting state baseline recording.
Time frame: 10 minutes of recording after isotonic/hypertonic injection
Collection of blood samples
Whole blood samples (5 mL per each time point, a total of 20 mL per subject) will be collected into SST™ II Advance Serum Separation Tubes containing anticoagulant EDTA.
Time frame: time 0 (baseline)
Collection of blood samples
Whole blood samples (5 mL per each time point, a total of 20 mL per subject) will be collected into SST™ II Advance Serum Separation Tubes containing anticoagulant EDTA.
Time frame: Time 1 (3 hours)
Collection of blood samples
Whole blood samples (5 mL per each time point, a total of 20 mL per subject) will be collected into SST™ II Advance Serum Separation Tubes containing anticoagulant EDTA.
Time frame: time 2 (24 hours)
Collection of blood samples
Whole blood samples (5 mL per each time point, a total of 20 mL per subject) will be collected into SST™ II Advance Serum Separation Tubes containing anticoagulant EDTA.
Time frame: time 3 (48 hours)
Collection of blood samples
Whole blood samples (5 mL per each time point, a total of 20 mL per subject) will be collected into SST™ II Advance Serum Separation Tubes containing anticoagulant EDTA.
Time frame: time 4 (72 hours)
MicroRNAs (miRNAs) expression analysis
From the blood samples previously collected, miRNA will be isolated for a subsequent miRNA library preparation. Subsequently, extracted miRNA will be reversely transcribed, and cDNA will be used for total miRNAs sequencing.
Time frame: time 0 (baseline)
MicroRNAs (miRNAs) expression analysis
From the blood samples previously collected, miRNA will be isolated for a subsequent miRNA library preparation. Subsequently, extracted miRNA will be reversely transcribed, and cDNA will be used for total miRNAs sequencing.
Time frame: time 1 (3 hours)
MicroRNAs (miRNAs) expression analysis
From the blood samples previously collected, miRNA will be isolated for a subsequent miRNA library preparation. Subsequently, extracted miRNA will be reversely transcribed, and cDNA will be used for total miRNAs sequencing.
Time frame: time 2 (24 hours)
MicroRNAs (miRNAs) expression analysis
From the blood samples previously collected, miRNA will be isolated for a subsequent miRNA library preparation. Subsequently, extracted miRNA will be reversely transcribed, and cDNA will be used for total miRNAs sequencing.
Time frame: time 3 (48 hours)
MicroRNAs (miRNAs) expression analysis
From the blood samples previously collected, miRNA will be isolated for a subsequent miRNA library preparation. Subsequently, extracted miRNA will be reversely transcribed, and cDNA will be used for total miRNAs sequencing.
Time frame: time 4 (72 hours)
Proteome analysis
From the blood samples previously collected, the protein concentration will be determined. Protein sequencing will be done using mass spectrometers.
Time frame: time 0 (baseline)
Proteome analysis
From the blood samples previously collected, the protein concentration will be determined. Protein sequencing will be done using mass spectrometers.
Time frame: time 1(3 hours)
Proteome analysis
From the blood samples previously collected, the protein concentration will be determined. Protein sequencing will be done using mass spectrometers.
Time frame: time 2 (24 hours)
Proteome analysis
From the blood samples previously collected, the protein concentration will be determined. Protein sequencing will be done using mass spectrometers.
Time frame: time 3 (48 hours)
Proteome analysis
From the blood samples previously collected, the protein concentration will be determined. Protein sequencing will be done using mass spectrometers.
Time frame: time 4 (72 hours)
Metabolome analysis
From the blood samples previously collected. Metabolites will be investigated and identified by a 4D feature finding using Metaboscape.
Time frame: time 0 (baseline)
Metabolome analysis
From the blood samples previously collected. Metabolites will be investigated and identified by a 4D feature finding using Metaboscape.
Time frame: time 1(3 hours)
Metabolome analysis
From the blood samples previously collected. Metabolites will be investigated and identified by a 4D feature finding using Metaboscape.
Time frame: time 2 (24 hours)
Metabolome analysis
From the blood samples previously collected. Metabolites will be investigated and identified by a 4D feature finding using Metaboscape.
Time frame: time 3 (48 hours)
Metabolome analysis
From the blood samples previously collected. Metabolites will be investigated and identified by a 4D feature finding using Metaboscape.
Time frame: time 4 (72 hours)
Plasma cortisol levels measurement
From the blood samples previously collected, plasma levels of cortisol will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 0 (baseline)
Plasma cortisol levels measurements
From the blood samples previously collected, plasma levels of cortisol will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 1(3 hours)
Plasma cortisol levels measurements
From the blood samples previously collected, plasma levels of cortisol will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 2 (24 hours)
Plasma cortisol levels measurements
From the blood samples previously collected, plasma levels of cortisol will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 3 (48 hours)
Plasma cortisol levels measurements
From the blood samples previously collected, plasma levels of cortisol will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 4 (72 hours)
Plasma Interleukin-6 (IL-6) levels measurements
From the blood samples previously collected, plasma levels of IL-6 will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 0 (baseline)
Plasma Interleukin-6 levels measurements
From the blood samples previously collected, plasma levels of IL-6 will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 1(3 hours)
Plasma Interleukin-6 levels measurements
From the blood samples previously collected, plasma levels of IL-6 will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 2 (24 hours)
Plasma Interleukin-6 levels measurements
From the blood samples previously collected, plasma levels of IL-6 will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 3 (48 hours)
Plasma Interleukin-6 levels measurements
From the blood samples previously collected, plasma levels of IL-6 will be evaluated through enzyme-linked immunosorbent assay (ELISA).
Time frame: time 4 (72 hours)
Measuring Pain using VAS
The subject will rate the pain intensity continuously for 20 minutes and VAS will start from zero (0), representing no pain, and will end at one hundred (100) representing worst pain imaginable.
Time frame: 20 minutes
Pain Catastrophizing Scale (PCS) questionnaire
The PCS assesses negative and exaggerated coping concerning anticipated or experienced painful stimuli. Thirteen items have to be answered on a 5-points Likert-type scale from 0 (non at all) to 4 (all the time).
Time frame: time 0 (baseline)
Positive and Negative Affect Schedule (PANAS) questionnaire
The PANAS measures positive affects (PA) dimensions ( "the extent to which a person feels active, enthusiastic, and alert") and negative affects (NA) dimensions (a condition of "general distress and unpleasable engagement"). Twenty words are associated with the subject's current feelings and have to be rated on a 5-points Likert-type scale from 1 (non at all) to 5 (extremely).
Time frame: time 0 (baseline)
Reinforcement Sensitivity Theory - Personality Questionnaire (RST-PQ).
The RST-PQ contains the following subscales: * Fight-Flight-Freeze System (FFFS, 10 items), related to active avoidance of adverse stimuli; * Behavioral Inhibition System (BIS, 23 items), related to anxiety and passive avoidance of adverse stimuli; * Behavioral Approach System (BAS, 32 items), it reflects reward interest, reward reactivity, impulsivity. In total, 65 items have to be answered on a 4-points Likert-type scale, from 1 (non at all) to 4 (highly).
Time frame: time 0 (baseline)
State-Trait Anxiety Inventory - Form Y (STAI-Y)
The STAI-Y questionnaire measures two types of anxiety, the state and the trait anxiety, as well as the severity of the overall anxiety level. The questionnaire is divided into two sections of 20 items each to be rated on a 4-points Likert-type scale from 1 (non at all) to 4 (very much).
Time frame: time 0 (baseline)
Heart rate assessment
An electrocardiogram (ECG) will be recorded with a standard 3-lead montage (one electrode on each wrist and the third on the left ankle)
Time frame: time 0 (baseline)
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2022 (actual). Primary completion is estimated for Dec 2024, 26 months after the start.
Of 425 non-industry interventional studies with no phase under Acute Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 26 months is above that.
Counting every sponsor, half of 431 studies reached it within 11 months; a quarter within 5 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.